Luo Shicheng, Wu Kaini, Zhou Xiaodong
Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
BMC Gastroenterol. 2025 Jul 1;25(1):488. doi: 10.1186/s12876-025-04088-3.
Endoscopy is a critical tool in the management of acute variceal bleeding (AVB). However, the optimal timing for its implementation remains controversial, with varying recommendations across different clinical guidelines. This study aims to evaluating the impact of endoscopy timing on patient outcomes.
PubMed, the Cochrane Library, and Embase were searched from the earliest available publication to January 31, 2024. Both fixed-effect and random-effect models were employed to calculate the odds ratio (OR) and 95% confidence intervals (CIs), based on the levels of heterogeneity. Newcastle-Ottawa Scale was used to assess the quality of each included studies. The mortality, incidence of rebleeding and other secondary outcomes were compared between urgent and early endoscopy groups. Subgroup analysis was performed based on the endoscopy time defined in each included studies and the reporting time of primary outcomes. The publication bias was examined through Egger’s test and Begg’s test.
Our analysis showed no significant difference in overall mortality (OR = 0.99, 95% CI, 0.60–1.62, = 0.96) and rebleeding (OR = 1.06, 95% CI, 0.77–1.47, = 0.71) as well as secondary outcomes between the two groups. Subgroup analysis indicated that the mortality in the 6–24 h endoscopy group was significantly lower than in the < 6 h endoscopy group (OR = 2.05, 95% CI, 1.29–3.26, = 0.002). However, no statistical difference between the other groups.
Endoscopy performed within 6 h might be associated with higher mortality. Furthermore, urgent and early endoscopy did not significantly affect other outcomes in AVB patients. Therefore, the timing for endoscopy would be more appropriate based on each patient’s condition within 24 h.
The online version contains supplementary material available at 10.1186/s12876-025-04088-3.
内镜检查是急性静脉曲张出血(AVB)管理中的一项关键工具。然而,其实施的最佳时机仍存在争议,不同的临床指南有不同的建议。本研究旨在评估内镜检查时机对患者结局的影响。
检索了从最早可用出版物到2024年1月31日的PubMed、Cochrane图书馆和Embase。根据异质性水平,采用固定效应模型和随机效应模型计算比值比(OR)和95%置信区间(CI)。使用纽卡斯尔-渥太华量表评估每项纳入研究的质量。比较紧急内镜检查组和早期内镜检查组的死亡率、再出血发生率及其他次要结局。根据每项纳入研究定义的内镜检查时间和主要结局的报告时间进行亚组分析。通过Egger检验和Begg检验检查发表偏倚。
我们的分析显示,两组之间的总体死亡率(OR = 0.99,95% CI,0.60 - 1.62,P = 0.96)、再出血率(OR = 1.06,95% CI,0.77 - 1.47,P = 0.71)以及次要结局均无显著差异。亚组分析表明,6 - 24小时内镜检查组的死亡率显著低于<6小时内镜检查组(OR = 2.05,95% CI,1.29 - 3.26,P = 0.002)。然而,其他组之间无统计学差异。
6小时内进行内镜检查可能与较高的死亡率相关。此外,紧急内镜检查和早期内镜检查对AVB患者的其他结局无显著影响。因此,根据每位患者的病情在24小时内进行内镜检查的时机可能更为合适。
在线版本包含可在10.1186/s12876 - 025 - 04088 - 3获取的补充材料。